Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: Evidence for intracellular endothelin-converting enzyme

Molecular Pharmacology

Volumn 55, Issue 5, 1999, Pages 902-909

  Woods, Mandy ^a   Mitchell, Jane A ^b   Wood, Elizabeth G ^a   Barker, Stewart ^a   Walcot, Nicholas R ^a   Rees, Gareth M ^a   Warner, Timothy D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 BIPHENYLYL) 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYLPHOSPHONIC ACID; CYTOKINE; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; GAMMA INTERFERON; MESSENGER RNA; PHOSPHORAMIDON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIOVASCULAR FUNCTION; COMPETITIVE INHIBITION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; VASCULAR SMOOTH MUSCLE;

EID: 0032959132     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Balwierczak JL, Wong M and Jeng AY (1993) A simple assay for the measurement of conversion of big endothelin-1 to endothelin-1 by smooth muscle. Eur J Pharmacol 250:379-384.
2. Beasley D and McGuiggin M (1994) Interleukin-1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J Exp Med 179:71-80.
3. Bishop-Bailey D, Larkin SW, Warner TD, Chen G and Mitchell JA (1997a) Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol 121:125-133.
4. Bishop-Bailey D, Pepper JR, Haddad EB, Newton R, Larkin SW and Mitchell JA (1997b) Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery. Arterioscler Thromb Biol 17:1644-1648.
5. Chomczynski P and Sacchi N (1987) Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Corder R, Harrison VJ, Khan N, Anggard EE and Vane JR (1993) Effect of phosphoramidon in endothelial cell cultures on the endogenous synthesis of endothelin-1 and on conversion of exogenous big endothelin-1 to endothelin-1. J Cardiovasc Pharmacol 22(Suppl 8):S73-S76.
7. Corder R, Khan N and Harrison VJ (1995) A simple method for isolated human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11. Biochem. Biophys Res Commun 207:355-362.
8. De Lombaert S, Ghai RD, Jeng AY, Trapani AJ and Webb RL (1994) Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem Biophys Res Commun 204:407-412.
9. Haug C, Voisard R, Lenich A, Baur R, Hoher M, Osterhues H, Hannekum A, Vogel U, Mattfeldt T, Hombach V and Grunert A (1996) Increased endothelin release by cultured human smooth muscle cells from atherosclerotic coronary arteries. Cardiovasc Res 31:807-813.
10. Haynes WG and Webb DJ (1993) The endothelin family of peptides: Local hormones with diverse roles in health and disease. Clin Sci 84:485-500.
11. Iktegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S (1991) Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells. FEBS Lett 293:45-48.
12. Inoue A, Yangisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K and Masaki T (1989) The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867.
13. Kanse SM, Takahashi K, Warren JB, Perera T, Porta M, Ghatei M and Bloom SR (1991) Production of endothelin by vascular smooth muscle cells. J Cardiovasc Pharmacol 17(Suppl. 7):S113-S116.
14. Kasuya H, Weir BK, White DFM and Stefansson K (1993) Mechanism of oxyhemoglobin-mduced release of endothelin-1 from cultured vascular endothelial cells and smooth muscle cells. J Neurosurg 79:892-898.
15. Klemm P, Warner TD, Hohlfeld T, Corder R and Vane JR (1995) Endothelin-1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Natl Acad Sci USA 92:2691-2695.
16. Maguire JJ, Johnson CM, Mockridge JW and Davenport AP (1997) Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol 122:1647-1654.
17. Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M and Morimoto S (1991) Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem Biophys Res Commun 178:899-905.
18. McMahon ET, Palomo MA and Moore WM 1991) Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol 17(Supppl 7):S29-S33.
19. Morin C, Asselin C, Boudreau F and Provencher PH (1998) Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem Biophys Res Commun 244:583-587.
20. Parris RJ and Webb DL (1997) The endothelin system in cardiovascular physiology and pathophysiology. Vasc Med 2:31-43.
21. Plumpton C, Haynes WG, Webb DJ and Davenport AP (1996) Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br J Pharmacol 116:1821-1828.
22. Ross R (1971) The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50:172-186.
23. Sawamura T, Kasuya Y, Matsushita Y, Suzuki N, Shinmi O, Kishi N, Sugita Y, Yanagisawa M, Goto K, Masaki T and Kimura S (1991) Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem Biophys Res Commun 174:779-784.
24. Schmidt M. Kroger B, Jacob E, Seulberger H, Subowski T, Otter R, Meyer T, Schmalzing G and Hillen H (1994) Molecular characterisation of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett 356:238-243.
25. Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Dumas Milne Edwards JB, Stumpf JG, Loffler and BM (1997) Human endothelin-converting enzyme (ECE-1): Three isoforms with distinct subcellular localizations. Biochem J 328:871-877
26. Shimada K, Takahashi M, Ikeda M and Tanzawa K (1995) Identification and characterisation of two isoforms of an endothelin-converting-enzyme. FEBS Lett 371: 140-144.
27. Shimada K, Takahashi M and Tanzawa K (1994) Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 269: 18275-18278.
28. Takeda Y, Itoh Y, Yoneda T, Miyamori I and Takeda R (1993) Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells. Eur J Pharmacol 233:299-301.
29. Trapani AJ, De Lombaert S, Kuzmich S and Jeng AY (1995) Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11. J Cardiovasc Pharmacol 26(Suppl 3):S69-S71.
30. Turner AJ (1993) Endothelin-converting enzyme and other families of metalloendopeptidases. Biochem Soc Trans 21:697-701.
31. Valdenaire O, Rohrbacher E and Mattei MG (1995) Organisation of the gene encoding the human endothelin converting enzyme (ECE-1). J Biol Chem 270:29794-29798.
32. Wang X, Douglas SA, Louden C, Vickery-Clarke LM, Feuerstein GZ and Ohlstein E (1996) Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1 and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 78:322-328.
33. Warner TD (1996) Influence of endothelial cell mediators on the vascular smooth muscle and circulating platelets and blood cells. Int Angiology 15:93-99.
34. Warner TD and Klemm P (1996) What turns on the endothelins? Inflamm Res 45:51-53.
35. Warner TD, Elliott JD and Ohlstein E (1996) California dreamin' 'bout endothelin: Emerging new therapeutics. Trends Pharmacol Sci 17:177-181.
36. Warner TD, Mitchell JA, D'Orleans-Juste P, Ishii K, Forstermann U and Murad F (1992) Characterization of endothelin-converting enzyme from endothelial cells and rat brain: Detection of the formation of biologically active endothelin-1 by rapid bioassay. Mol Pharmacol 41:399-403.
37. Wong JM and Billiar TR (1995) Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 34:155-170.
38. Woods M, Bishop-Bailey D, Pepper JR, Evans TW, Mitchell JA and Warner TD (1998) Cytokine and lipopolysaccharide stimulation of endothelin-1 release from internal mammary artery and saphenous vein smooth muscle cells. J Cardiovasc Pharmacol 31(Suppl. 1):S348-S350.
39. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D and Yangisawa M (1994) ECE-1: A membrane-bound metalloprotease that catalyses the proteolytic activation of big enothelin-1. Cell 78:473-485.
40. Yangisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki TA (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415.
41. Yu JCM and Davenport AP (1995) Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol 114:551-557.